TTI1

Across TCGA pan-cancer cohorts, TTI1 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated TTI1 data layer compared with 28 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher TTI1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TTI1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

THYM, COAD, and LUAD are the cancer types where TTI1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →
COAD	OS	Median	All	0.231	0.618	.016	18	view →
LUAD	OS	Median	II,III,IV	0.137	0.756	<.001	18	view →
PAAD	OS	Median	All	0.110	0.640	<.001	12	view →
UCEC	DFS	Median	II,III,IV	0.883	0.301	.014	8	view →
SKCM	DFS	Median	All	0.538	0.742	.016	4	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

TTI1–THYM (OS)

Open the THYM breakdown →